Effect of Preoperative Diabetes Management on Glycemic Control and Clinical Outcomes after Elective Surgery

Annals of Surgery

Volumn 267, Issue 5, 2018, Pages 858-862

  Garg, Rajesh ^a   Schuman, Brooke ^a   Bader, Angela ^a   Hurwitz, Shelley ^a   Turchin, Alexander ^a,b   Underwood, Patricia ^c   Metzger, Cheyenne ^a   Rein, Raquel ^a   Lortie, Meghan ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

elective surgery; length of hospital stay; postoperative outcomes; preoperative diabetes management

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; DIABETES MELLITUS; DRUG USE; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITAL READMISSION; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; AGED; BLOOD; CLINICAL TRIAL; FOLLOW UP; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MASSACHUSETTS; METABOLISM; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PROCEDURES; TRENDS;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INFUSIONS, INTRAVENOUS; INSULIN; LENGTH OF STAY; MALE; MASSACHUSETTS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 85019770015     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002323     Document Type: Article

References (32)

1. Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783-1788.
2. Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37:88-99.
3. Ramos M, Khalpey Z, Lipsitz S, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg. 2008;248:585-591.
4. Sathya B, Davis R, Taveira T, et al. Intensity of peri-operative glycemic control and postoperative outcomes in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2013;102:8-15.
5. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34: 256-261.
6. Underwood P, Askari R, Hurwitz S, et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37:611-616.
7. Hommel I, van Gurp PJ, Tack CJ, et al. Perioperative diabetes care: room for improving the person centredness. Diabet Med. 2015;32:561-568.
8. Pasquel FJ, Gomez-Huelgas R, Anzola I, et al. Predictive value of admission hemoglobin a1c on inpatient glycemic control and response to insulin therapy in medicine and surgery patients with type 2 diabetes. Diabetes Care. 2015;38:e202-e203.
9. Alexiewicz JM, Kumar D, Smogorzewski M, et al. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med. 1995;123:919-924.
10. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
11. Hilbe JM. Negative Binomial Regression. New York: Cambridge University Press; 2011.
12. Rappleye E. Average Cost Per Inpatient Day Across 50 States 2015. Available at: http://www.beckershospitalreview.com/finance/average-cost-per-inpatient-day-across-50-states.html. Accessed December 17, 2015.
13. Fraze T, Jiang J, Burgess J, et al. Hospital Stays for Patients with Diabetes, 2008 2010. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb93.pdf. Accessed September 9, 2015.
14. Marchant MHJr, Viens NA, Cook C, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91:1621-1629.
15. Buehler L, Fayfman M, Alexopoulos AS, et al. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. J Diabetes Complications. 2015;29:1177-1182.
16. Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17:R37.
17. Kwon S, Thompson R, Dellinger P, et al. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg. 2013;257:8-14.
18. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-360. discussion 360-362.
19. Carral F, Aguilar M, Olveira G, et al. Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. J Diabetes Complications. 2003;17:331-336.
20. Lilienfeld DE, Vlahov D, Tenney JH, et al. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. Am J Infect Control. 1988;16:3-6.
21. Szabo Z, Hakanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2002;74:712-719.
22. Fohl AL, Butler SO, Patil PV, et al. The association between hemoglobin A1C values and deep sternal wound infections in diabetes patients undergoing cardiac surgery. Cardiovasc Endocrinol. 2013;2:15-22.
23. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-1502.
24. King JT Jr, Goulet JL, Perkal MF, et al. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg. 2011;253: 158-165.
25. Endara M, Masden D, Goldstein J, et al. The role of chronic and perioperative glucose management in high-risk surgical closures: a case for tighter glycemic control. Plast Reconstr Surg. 2013;132:996-1004.
26. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med. 2001;345:1359-1367.
27. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
28. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
29. Dhatariya K, Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29:420-433.
30. Jamsen E, Nevalainen P, Kalliovalkama J, et al. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med. 2010;21:196-201.
31. Walid MS, Newman BF, Yelverton JC, et al. Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost. J Hosp Med. 2010;5:E10-E14.
32. Strack B, DeShazo JP, Gennings C, et al. Impact of HbA1c measurement on hospital readmission rates: analysis of 70,000 clinical database patient records. BioMed Res Int. 2014;2014:11.